TrialPloS one2016

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.

Anna Miquel-Cases et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.